Knights of Columbus Asset Advisors LLC

Position in NVO — Novo Nordisk A S

CIK 1688666 NEW HAVEN, CT

Position in NVO

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$140,512

-$24,605 QoQ

Shares Held

2,931

-34.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#1,052

of 1,348 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Knights of Columbus Asset Advisors LLC holds $16,766,377 across 10 Drug Manufacturers - General names. NVO ranks #7 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	109,712	$13,861,014
2	LLY	ELI LILLY & Co	1,091	$1,308,578
3	JNJ	Johnson & Johnson	1,421	$360,891
4	ABBV	AbbVie Inc.	1,391	$350,031
5	BMY	Bristol Myers Squibb Co	4,940	$284,642
6	NVS	Novartis AG	1,585	$248,401
7	NVO	Novo Nordisk A S This page	2,931	$140,512
8	SNY	Sanofi	2,405	$102,597

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$140,512	2,931	-34.8%	Shares	Sole	2026-07-31
2026-03-31	$165,117	4,493	0.0%	Shares	Sole	2026-05-11
2025-12-31	$228,603	4,493	0.0%	Shares	Sole	2026-02-09
2025-09-30	$249,316	4,493	+2.4%	Shares	Sole	2025-11-03
2025-06-30	$302,721	4,386	0.0%	Shares	Sole	2025-07-22
2025-03-31	$304,563	4,386	-4.6%	Shares	Sole	2025-05-07
2024-12-31	$395,519	4,598	+9.0%	Shares	Sole	2025-02-11
2024-09-30	$502,237	4,218	+23.5%	Shares	Sole	2024-11-12
2024-06-30	$487,599	3,416	0.0%	Shares	Sole	2024-07-30
2024-03-31	$438,614	3,416	+59.5%	Shares	Sole	2024-05-10
2023-12-31	$221,589	2,142	+99.8%	Shares	Sole	2024-01-31
2023-09-30	$97,487	1,072	+110.2%	Shares	Sole	2023-11-01
2023-06-30	$82,533	510	—	Shares	Sole	2023-08-01
No filing history on record for this holder in this stock.